Chargement en cours...
Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
Although available data are conflicting, psoriasis seems to be associated with an increased baseline risk of malignancy. In addition, some antipsoriatic systemic treatments have been associated with risk of malignancy. There is not enough data on the association of interleukin (IL)-17 and IL-23 inhi...
Enregistré dans:
| Publié dans: | Case Rep Dermatol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger AG
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816125/ https://ncbi.nlm.nih.gov/pubmed/31662733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501993 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|